Cologne

Vaccine Developed by Mustafa Prize Laureate 90% Effective, Pfizer Confirms

Rokna: The COVID-19 vaccine developed by BioNTech, co-founded by the 2019 Mustafa (PBUH) Prize laureate Ugur Sahin, and Pfizer, is found to be more than 90% effective based on initial trial results,…